Multi-institutional investigation: Biomarker identification for proper use of Nivolmab for head and neck cancer.
Not Applicable
- Conditions
- head and neck cancer
- Registration Number
- JPRN-UMIN000036976
- Lead Sponsor
- Department of Head and Neck Surgery, Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patient without the history of treatment of the chemotherapy including the platinum Patient who received Nivolmab as adjuvant chemotherapy The patient who received a combination with other anti-cancer agents
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method